Stay updated on Trial of ZW25 in Advanced HER2+ Cancers Clinical Trial

Sign up to get notified when there's something new on the Trial of ZW25 in Advanced HER2+ Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trial of ZW25 in Advanced HER2+ Cancers Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:03:54.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a significant update in the ongoing Phase I Trial of ZW25 in Patients With Locally Advanced and/or Metastatic HER2-expressing Cancers. This change may reflect new data or developments in the investigation of the safety, tolerability, and effectiveness of ZW25 in combination with selected chemotherapy agents.
    Difference
    0.1%
    Check dated 2024-06-06T14:35:20.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participation in the clinical trial, specifying the types of HER2-expressing cancers and prior treatments required for inclusion. Previously, no information was provided under the Participation Criteria section.
    Difference
    45%
    Check dated 2024-05-22T21:33:16.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T22:40:18.000Z thumbnail image

Stay in the know with updates to Trial of ZW25 in Advanced HER2+ Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trial of ZW25 in Advanced HER2+ Cancers Clinical Trial page.